FILING ANALYSIS · WEDNESDAY, NOVEMBER 4
Adaptive Biotechnologies Corp ADPT — 8-K: Results of Operations and Financial Condition
positive
Adaptive Biotechnologies achieved total company profitability ahead of expectations, delivered 44% growth in core MRD revenue, and raised full-year 2026 MRD revenue guidance to a range of $276 million to $286 million, representing annual growth of 30% to 35%
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →